Bioequivalence Study of Lamotrigine Tablets 25 mg (2 x 25 mg Tablets) Under Fasting Condition

NCT01618799 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Fasting State

Interventions

DRUG: Lamotrigine Tablets 25 mg
DRUG: Lamotrigine

Sponsor

IPCA Laboratories Ltd.